Connect with us

Health

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms – News-Medical.net

Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.

Published

on

Article feature image

Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, the ACTIV-6 trial aims to provide evidence-based…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Dapagliflozin Misses Early Mark in COVID-19, but Kosiborod Sees Reasons for More Study – AJMC.com Managed Markets Network
Article feature image
Late-Breaking Data at ACC.21 Show XARELTO® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization – PRNewswire